Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Elite Pharmaceuticals, a developer of oral sustained and controlled release products, has entered into a manufacturing and supply pact with ThePharmaNetwork and its wholly owned subsidiary Ascend Laboratories (collectively TPN).
Subscribe to our email newsletter
Elite operates a GMP and DEA registered facility in Northvale, NJ for research, development and manufacturing.
Under the agreement, Elite will manufacture and package TPN’s Methadone Hydrochloride, 10mg tablets.
Elite chairman and CEO Jerry Treppel said they are pleased to assist TPN with the launch and commercialization of their Methadone product and in light of the recent action by the FDA with the Lodrane family of products, this agreement will help Elite buffer the impact by providing a new revenue stream.